Eosinophil Inflammation of Nasal Polyp Tissue: Relationships with Matrix Metalloproteinases, Tissue Inhibitor of Metalloproteinase-1, and Transforming Growth Factor-β1

Journal of Korean Medical Science

Volumn 18, Issue 1, 2003, Pages 97-102

  Lee, Young Mok ^a   Kim, Sun Sin ^b   Kim, Hyun Ah ^b   Suh, Yu Jin ^b   Lee, Soo Keol ^b   Nahm, Dong Ho ^b   Park, Hae Sim ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Eosinophils; Matrix Metalloproteinases; Nasal Polyps; Tissue Inhibitor of Metalloproteinase 1; Transforming Growth Factor beta

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TRYPTASE; EOSINOPHIL GRANULE PROTEIN; PLASMA PROTEIN; RIBONUCLEASE; SERINE PROTEINASE; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MAST CELL; NOSE POLYP; POLYPECTOMY; STATISTICAL SIGNIFICANCE; SWEDEN; TISSUE HOMOGENATE; ASTHMA; CHEMISTRY; EOSINOPHILIA; METABOLISM; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; RHINITIS;

ADULT; ASTHMA; BLOOD PROTEINS; CHEMOTAXIS, LEUKOCYTE; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NASAL POLYPS; RHINITIS; RIBONUCLEASES; SERINE ENDOPEPTIDASES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRYPTASES;

EID: 0141924194     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2003.18.1.97     Document Type: Article

References (30)

1. Stierna PLE. Nasal polyps: relationship to infection and inflammation. In: Settipane CA, Lund VJ, Berstein JM, Tos M, eds. Nasal Polyps: Epidemiology, Pathogenesis and Treatment. OceanSide Publications; Providence, RI; 1997: 119-26.
2. Hamilos DL. Nasal polyps as immunoreactive tissue. Allergy Asthma Proc 1996; 17: 293-6.
3. Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Lymphocytes and non-lymphoid cells in human nasal polyps. J Allergy Clin Immunol 1991; 87: 470-5.
4. Kawabori S, Denburg JA, Schwarz LB, Irani AA, Wong D, Jordana G, Evans S, Dolovich J. Histochemical and immunohistochemical characteristic of mast cells in nasal polyps. Am J Respir Cell Mol Biol 1992; 6: 37-43.
5. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142: 863-71.
6. Norlander T, Westrin KM, Fukami M, Stierna P, Carlsoo B. Experimentally induced polyps in the sinus mucosa: a structural analysis of the initial stages. Laryngoscope 1996; 106: 196-203.
7. Hoshino M, Takahashi M, Takai Y, Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergv Clin Immunol 1999; 104: 356-63.
8. Lechapt-Zalcman E, Coste A, d'Ortho MP, Frisdal E, Harf A, Lafuma C, Escudier E. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001; 193: 233-41.
9. Nagase H. Activation mechanisms of matrix metalloproteinase. Biol Chem 1997; 378: 151-60.
10. Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, Isoyama S, Tanno Y, Tamura G, Yamauchi K, Nagura H, Shirato K. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997; 16: 212-9.
11. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H. Human mast cells produce matrix metalloproteinase 9. EurJ Immunol 1999; 29: 2645-9.
12. Fang KC, Wolters PJ, Steinhoff M, Bidgol A, Blount JL, Caughey GH. Mast cell expression of gelatinase A and B is regulated by kit ligand and TGF-β1. J Immunol 1999; 162: 5528-35.
13. Elovic A, Wong DT, Weller PF, Matossian K, Galli SJ. Expression of transforming growth factor-α and β1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994; 93: 864-9.
14. Sehgal I, Thompson TC. Novel regulation of type IV collagenase (matrix metallo proteinase-9 and -2) activities by transforming growth factor β1 in human prostate cancer cell lines. Mol Biol Cell 1999; 10: 407-16.
15. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-44.
16. Rhichie RF, Alper CA, Graves J, Pearson N, Larson C. Automated quantitation of proteins in serum and other biologic fluids. Am J Clin Pathol 1973; 59: 151-9.
17. Park HS, Nahm DH, Park K, Suh KS, Yim HE. Immunohistochemical characterization of cellular infiltrate in nasal polyp from aspirin-sensitive asthmatic patients. Ann Allergy Asthma Immunol 1998; 81: 219-24.
18. Keith PK, Conway M, Evans S, Wong DA, Jordana G, Pengelly D, Dolovich J. Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol 1994; 93: 567-74.
19. Redington AE, Howarth PH. Mast cells, cytokines and asthma. Can Respir Dis 1994; 1: 1-9.
20. Okayama Y, Kobayashi H, Ashman LK, Holgate ST, Church MK, Mori M. Activation of eosinophil with cytokines produced by lung mast cells. Int Arch Allergy Immunol 1997; 114(Suppl 1): 75-7.
21. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997; 17: 519-28.
22. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992; 89: 958-67.
23. Schwartz LB, Bradford TR, Irani AM, Dblois G, Craig SS. The major enzymes of human mast cell secretory granules. Am Rev Respir Dis 1987; 135: 1186-9.
24. Lee HM, Choi JH, Choi CS, Hwang SJ, Lee SH. Expression of MMP-9 and TIMP-1 in the nasal mucosa of allergic rhinitis. Korean J Otolaryngol 2000; 43: 604-9.
25. Mautino G, Capony F, Bousquet J, Vignola AM. Balance in asthma between matrix metalloproteinases and their inhibitors. J Allergy Clin Immunol 1999; 104: 530-3.
26. Lemjabbar H, Gosset P, Lamblin C, Tillie I, Hartmann D, Wallaert B, Tonnel AB, Lafuma C. Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med 1999; 159: 1298-307.
27. Mautino G, Henriquet C, Jaffuel D, Bousquet J, Capony F. Tissue inhibitor of metalloproleinase-1 levels in bronchoal veolar fluid from asthmatics subjects. Am J Respir Crit Care Med 1999; 160: 324-30.
28. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 1999; 14: 163-76.
29. de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, van Krieken JH. Transforming growth factor β1 and recruitment of macrophage and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1951-7.
30. Drake-Lee A, Price J. Mast cell ultrastructure in the inferior turbinate and stroma of nasal polyps. J Laryngol Otol 1997; 111: 340-5.